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Research Article 
INTRODUCTION 
Coronavirus has recently emerged as SARS-CoV-2 
(Severe Acute Respiratory Syndrome Corona Virus), 
causing great despair worldwide. As per the World 
Health Organization, total 10,838,194 confirmed cases 
of Covid-19 and 1,55,080 deaths were reported in In-
dia, as on 8 February, 2021 (WHO, India Situation Re-
port, 54). Most affected states in India were Maharash-
tra, Karnataka, Andhra Pradesh, Tamil Nadu, Kerala, 
and Delhi (MOHFW, 2020). The mitigation methods 
included screening of symptomatic cases and contain-
ment of asymptomatic cases which were coming 
through air travel and cases due to contact with the 
infected ones (MOHFW, 2020). The same was also 
recommended by a study set when the cases in India 
were merely 3, modelled to find the strategies to work 
towards the outbreak (Mandal et al., 2020). 
There were several instances earlier too where mem-
bers of Coronaviridae family has caused diseases like 
SARS-CoV in 2002 and MERS-CoV (Middle East Res-
piratory Syndrome coronavirus) in 2012 (Hilgenfeld and 
Peiris, 2013; Lu et al., 2015). Even earlier than SARS 
and MERS-CoV, coronavirus was responsible for res-
piratory infections. Human coronavirus (HCoV) was 
mentioned in earlier studies on infants, children in Indi-
an states with fewer than 5% morbidity while studying 
respiratory pathogens (Malhotra et al., 2016; Sona-
wane et al., 2019). Coronavirus was also reported from 
domestic and wild animals of Indian states like Uttar 
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Pradesh (Rai et al., 2011), Orissa (Behera et al., 2015), 
Haryana (Agnihotri et al., 2018) and others (Hansa et 
al., 2012a, b). 
Novel Coronavirus (n-Cov) has highly adapted strains 
as a result of genetic recombination and mutation (Lu et 
al., 2020). Being prevalent in diverse animals like bats, 
camels, cats, rodents etc. surrounding humans, it can 
be easily transmitted to humans (Ye et al., 2020). The 
SARS-CoV-2 (originated in China) is spreading faster 
than SARS-CoV and MERS-CoV with less mortality and 
high recovery (Chen, 2020). We have analysed popula-
tion at risk and updated on the newly emerged corona-
virus situation in India through epidemiology, on-going 
treatment, and control strategies.   
METHODS 
We searched for keywords “Covid-19”, “SARS-CoV-2”, 
“coronavirus India” on Pubmed, Google scholar and 
Web of Knowledge. We also went through news articles 
and situation reports of the World Health Organization, 
Advisory of Indian Council of Medical Research, Delhi 
and Ministry of Health and Family Welfare for infor-
mation on the pandemic.  Data on individual level Covid
-19 cases in India from 30th January 2020 till 26th April 
2020 were obtained from Kaggle (https://
www.kaggle.com/sudalairajkumar/covid19-in-india). 
WHO, Corona tracker India, census, IDSP (Integrated 
Diseases Surveillance Program) and worldometer web-
sites were also referred to wherever perti-
nent. Association of Covid-19 cases and deaths for the 
population at risk was conducted using Chi-square test 
at p-value 0.05. For all statistical test, MS excel 2013 
(15.0.5172.1000) was used.  
About 2019-nCoV 
Coronavirus belongs to family Coronaviridae and order 
Nidovirales. This family has four genera, of which 
SARS-CoV and n-CoV-19 belong to genera Betacoro-
navirus, subgenera Sarbecovirus. Till now, seven coro-
naviruses from humans were identified. These are com-
mon human CoVs like HCoV-OC43, HcoV-HKU1, HcoV
-229E, HCoV-NL63 and others like SARS-CoV, SARS-
CoV-2, and MERS-CoV. Except for HCoV-229E, and 
HCoV-NL63 (belonging to alphaCoV) all others belong 
to betaCoV (Zhu et al., 2020; Zhang et al., 2020). In 
India, several investigations reported coronavirus to 
cause respiratory diseases in humans. Four corona-
viruses, namely HKU1, NL63, 229E and OC43 were 
found among humans earlier (Singhal, 2020). In 2002-
2003, a new coronavirus designated as severe acute 
respiratory syndrome coronavirus emerged in China 
and Hong Kong with 11% mortality (Chan Yeung and 
Xu, 2003). Again in 2012, MERS-CoV appeared with a 
fatality rate of 34 % (Memish et al., 2013). In 2019, 
SARS-CoV-2 appeared in the Wuhan city, Hubei prov-
ince of China. This disease spread to other countries 
through the migration of population during Chinese 
New Year (Zhou et al., 2020; Jiang and Luo, 2020). 
The preliminary phylogenetic analysis reported snakes 
to be its natural hosts, but this hypothesis was rejected 
(Zhang et al., 2020). Later, researchers identified bat 
as its host as it was nearest to Bat SARS-like CoVs 
(Bat-SLCoVs, MG772933 and MG772934) in phyloge-
netic analysis (Guo et al., 2020; Malik et al., 2020). It 
shares 80% and 50% genetic sequence resemblance 
to SARS-CoV and MERS-CoV, respectively. Both 
SARS-CoV and MERS-CoV transmission initiated from 
bats and passed on to humans via an intermediate host 
like palm civet cats in case of SARS-CoV and camels 
in case of MERS-CoV (Lu et al., 2020; Ye et al., 2020). 
It is suggested that new coronavirus (2019-nCoV) is 
most closely related with the BatCoV RaTG13 discov-
ered in bats from Yunnan Province hence originated 
from the bat (Parakevis et al., 2020; Dhama et al., 
2020). The intermediary animal responsible for the 
transmission of nCoV-19 from the bat is still unidenti-
fied, snakes and pangolins suspected to play as inter-
mediate (Yadav et al., 2020). Covid-19 is still under the 
preliminary stage of research and more insight is ex-
pected to its origin. 
Epidemiology of Covid-19 in India 
The emergence of new coronavirus was detected in 
China on January 7, 2020. After two months i.e., on 
11th March 2020, WHO declared Novel Coronavirus 
outbreak as a pandemic. On 22 March 2020, first lock-
down and restriction on international travel was im-
posed. After the initial three confirmed cases recorded 
from Kerala in India (30th January, 2020) with travel 
history from Wuhan, this viral disease had numerous 
cases. Fig. 1 (data till 26th April as restriction on travel 
within and outside India was imposed) shows that trav-
ellers were mainly from Arab countries (Dubai, UAE, 
Iran, and Abu Dhabi) followed by European countries 
(maximum from Italy). Covid-19 infected travellers with-
in India were also found with maximum contribution 
from Delhi and Maharashtra (others are Kerala, Tamil 
Nadu, Madhya Pradesh, West Bengal, Gujarat, and 
Uttar Pradesh). By 26th April 2020, only 5.18% cases 
had travelled outside India and others were either hav-
ing a travel history within India or were close contact of 
the infected travellers. Hence, population move-
ment possesses a major role in the progress of Covid-
19 disease within and across countries. Metropolitan 
cities like Delhi, Mumbai, Thrissur, and Chennai were 
the majorly affected areas as they are well connected 
by air travel to other infected countries (Wadhawan et 
al., 2020, Sardar et al., 2020).  
As on 8 February 2021, the numbers of Covid-19 posi-
tive cases in India were 10, 847,790 with deaths being 
155,080. Daily increase in a number of COVID-19 cas-
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es indicate >500 cases per day following April, 1, 2020 
>1000 cases per day following April 20, 2020, > 2000 
cases per day May 1, 2020, >20,000 cases per day 
from June 30 onwards. Maharashtra, Andhra Pradesh, 
Kerala, Karnataka, Tamil Nadu, and Delhi were the 
worst affected states. Based on the number of novel 
coronavirus cases districts were classified into a 
hotspot (as on 1st May, 2020) which were marked as 
red zone (where a large number of positive cases were 
reported), non-hotspots districts or orange zone 
(recorded lesser number of positive cases), and green 
zone (where no fresh cases have been reported for 
some time). Delhi (100% hotspots) and Maharashtra 
(68.42%) have the largest number of hotspots on 1st 
May, 2020. The percentage of hotspots decreased for 
Maharashtra (38.89 %) while remained same for Delhi 
(100%) by 31st December 2020 (Fig. 2).  
Earlier reports show about 21% healthcare workers 
were affected during SARS outbreak. In India owing to 
COVID-19, 25 healthcare workers containing Doctors, 
nurses, compounders and other hospital staff were in-
fected since the appearance of the first case, i.e., in 75 
days (till 26th April 2020). The shocking report of Bhil-
wara, Rajasthan had 15/19 cases of medical practition-
ers showing the vulnerability of health care profession-
als to the Covid-19 (Parikh et al., 2020). These data 
showed that healthcare workers are at high risk. 
Data showed all ages to be susceptible to maximum 
cases from the age group of 21-40 years (46%). Larg-
est numbers of cases were from the age group 21-40 
(44 % on 26th April, 2020 and 48 % on 15th February 
2021) (Fig. 4). The mortality rate was estimated to be 
0.27%. The association of prevalence of novel corona-
virus disease with age was also found significant by chi
-square test at p < 0.05 (df=4, χ2statistic=94.75, 
χ2crtical=9.488, alpha=0.05%, p-value is < 0.00001).  
The data (till 14th April 2020, India) analysis showed 
males (df=4, χ2statistic= 581.97, p-value < 0.00001, 
significant at p < 0.05) to be more susceptible as ap-
proximately 70% males showed morbidity and mortality 
with Covid-19 as compared to females (df=4, χ2statistic 
=23.56, p-value= 0.023361, significant at p < 0.05) 
(Table 1). This is similar to the case of Italy (71%) and 
Spain (twice to a female) where more men were found 
susceptible (more died as compared to women) 
(Bakrania et al., 2020). The data at different times (6 
April, 21 July, 4 August, 11 August and 1st September 
2020) showed that males are having higher number of 
cases compared to females (Fig. 3).  
Role of social distancing  
Social distancing to reduce contact was suggested to 
prevent virus transmission (Bai, 2020). Social distanc-
ing is based on the principle of decreasing the basic 
reproductive number. Studies on basic reproductive 
number (R0) were done by many authors. For example, 
the importance of feasibility of controlling the outbreak 
in a country shows the effectiveness of isolation of a 
case to control Covid-19 within 3 months, if R0 is 2.5 
and transmission 15%. The probability of transmission 
becomes higher with the longer period (R0 more than 
2.5) as it requires a large number of contacts need to 
be traced and isolated which might not be possible 
(Hellewell et al., 2020). For slowing down the spread of 
Covid-19, less than 63% of social distancing is required 
(Jha et al., 2020). Swot analysis indicated the effective-
ness of social distancing based on R0 showed failure in 
implementation on the part of the public like religious 
gatherings (case of Tablighi Jamaat) and migrant work-
ers travel (Davey et al., 2020; Thurackal et al., 2020). 
The quarantine of positive and suspected cases and 
social distancing can slow the spread of novel corona-
virus if executed properly. However, to stop it com-
pletely, antivirals and vaccines are necessary.   
Role of wearing masks  
The practice of wearing masks has been followed for 
preventing the spread of infectious diseases like influ-
enza H1N1. Covid -19 patients release aerosols during 
exhalation, which can be spread to other people 
around them. Thus, using masks can impact turbulent 
gas cloud formation and can filter viral particles. It is 
reported that wearing the mask can reduce the viral 
reproduction number in the population (Cavanagh and 
Wambier, 2020; Li et al., 2020a, b; Lotfinejad et al., 
2020). 
Studies indicate that the virus is exhaled during talking 
and breathing. These aerosols contain viral load, which 
was detected to less than three hours as observed in 
human respiratory samples. Surgical masks can only 
prevent large sized droplets and sprays. The effective-
ness of surgical masks and N-95 respirators to protect 
against SARS-CoV-2 was found similar. The recent 
report of asymptomatic patients being a carrier of this 
virus has made the universal wearing of masks  
essential (Rundle et al., 2020; Roy et al., 2020) 
Fig. 1. Cases with travel history outside India (till travel 
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Role of washing hands  
Washing of hands with soap for an average of 20 sec-
onds and alcohol-based sanitizer have been reported 
as the effective methods to reduce transmission of 
Covid-19 (Roy et al., 2020). These are low-cost method 
that can denature the virus by acting on the envelope 
protein. However, some studies reported damage to 
skin on frequent washing of hands which creates a 
route of entry for Covid-19 (Rundle et al., 2020; 
Marwah and Marwah, 2020). It can also cause patho-
physiological changes, excessive skin dryness and 
several types of allergies of the skin. Yan et al. (2020) 
suggested the use of creams/moisturising after wash-
ing of hands and use of quality sanitizers. Creams/
moisturisers containing humectants with occlusive 
emollients acts as skin barrier and attracts water as 
well as prevent water loss thus moisturize skin (Beiu et 
al., 2020; Esposito et al., 2020). 
Demographical changes by urbanization impacting 
novel corona virus transmission 
Urbanization and population movement have caused 
the advancement of this virus within and across coun-
tries. The emergence of novel coronavirus occurred in 
China in December 2020, but spread to Japan, South 
Korea and Thailand by air travel by January 2020. 
Once this virus entered a country, population density 
played its role in its transmission (Bhatia and Devula-
palli, 2020). India has 5 megacities which are projected 
to 10 by 2030 (UNDESA, 2018). Cities with a large 
number of people accumulated in small area, especially 
slums are more prone to Covid-19 infection. People 
residing in the urban cities are more likely to infect with 
Covid-19, as their respiratory system is affected by the 
pollution and make them easy prey (Kaneda and 
Greenbaum, 2020; Wu et al., 2020).  
When some randomly selected districts were compared 
using population density, affluence per cent, and Covid-
19 cases and deaths, a significant relationship was 
found as metropolitan cities like Bangalore, Mumbai, 
Chennai were most affected (Fig. 5). District wise com-
parison of affluence with a number of cases showed 
most of the red zone districts (districts with a large num-
ber of cases) are more affluent than green and orange 
ones. The population density and affluence percentage 
were further analysed by correlating with Covid-19 cas-
es and deaths using Pearson's Coefficient. It was found 
that population density has a higher influence on Covid-
19 cases (0.28, p>0.01) and deaths (0.59, p>0.01) as 
compared to affluence (Fig. 6). Population density and 
type of zone were not found related to each other signif-
icantly (at p < 0.05) by Chi-square test 
(χ2statistic=2.0773, p-value=0.721539). This may be 
due to the fact that affluence is also influencing Covid-
19 cases in the three zones. Thus, Covid-19 cases in 
districts of India are influenced by population density as 
well as affluence. Neither affluence nor population  
density is singly acting as a variable affecting Covid-19 
Fig. 2. Comparison of hotspots (red zone with other zones) from May 3, 2020 to December 31, 2020 in different states of 
India. (Source:https://www.kaggle.com/sudalairajkumar/covid19-in-india/; https://www.oneindia.com/coronavirus-affected
-cities-districts-in-india) 
Fig. 3.  Change in Covid-19 viral disease cases by Gender 
(Male/Female) from January 6 April, 2020 to 1 September, 
2020 (Source: Kaggle.com/IDSP). 
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cases. Therefore, highly affluent districts with high pop-
ulation density are at higher risk of novel coronavirus 
disease. More urbanized, densely packed and prosper-
ous districts with migrants are more vulnerable to novel 
coronavirus (Bhatia and Devulapalli,2020). 
Testing protocol of the Covid-19 
Timely management of coronavirus disease requires 
accurate laboratory testing for detecting ILI cases i.e., 
Influenza-Like Illness cases (those with acute respirato-
ry infection, fever >38ºC and cough) and asymptomatic 
cases. Some laboratory tests identify the genetic mate-
rial (e.g., Real-Time Polymerase Chain Reaction) while 
other specific antibodies to SARS-CoV-2 (e.g., Rapid 
Antigen Test). RTPCR (Real-Time Polymerase Chain 
Reaction) is the gold standard that requires specialized 
laboratory set up. It can accurately detect Covid-19 
virus hence recommended as a confirmatory test.  
Point of care (POC) diagnostics have been developed, 
which are rapid tests like Rapid Antigen Test (RAT), 
allowing testing even outside the laboratory. Although 
used for detecting SARS-CoV-2 yet can be validated 
Fig. 4. Agewise comparison of coronavirus cases in India in ten months duration.(Source: Kaggle.com/IDSP 15th Feb 
2021) 
Fig. 5. Relationship of population density and affluence percentage of some of the selected districts with novel corona-
virus disease, i.e., cases and deaths. 
26th April 2020 15th Feb 2021 
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only after confirmation by RTPCR. Cartridge Based 
Nucleic Acid Amplification Test (CBNAAT) like 
TrueNaT and Cepheid Xpert Xpress SARS-CoV-2 are 
in use for testing in India (ICMR, 2020a). TrueNat has 
three types of assays i.e., TrueNat Beta CoV E gene 
screening assay, TrueNat SARS CoV2 RdRp gene 
confirmatory test and TrueNat Covid-19 multiplex as-
say. First samples are screened for E gene using the 
first assay. Negative results considered to be true neg-
ative while positive samples go through RdRp gene 
confirmatory test and if positive are true positives. Mul-
tiplex Assay comprises both screening (E gene) and 
confirmatory (Orf1a) in a single test. No RTPCR confir-
mation is required after TrueNat Assay. As per ICMR 
advisories, symptomatic (ILI symptoms) cases, high 
risk and direct contact asymptomatic cases (including 
elderly > 65 years in containment zones having comor-
bidities) should be tested with RAT and RT-PCR, 
TrueNat or CBNAAT. RAT is a test of priority in con-
tainment areas while RT-PCR in non-containment are-
as (exept for asymptomatic elders ageing> 65years). 
Single RTPCR/TrueNaT/CBNAAT/RAT test if positive, 
considered confirmatory (ICMR advisory version IV, 
dated 4th September, 2020). Convalescent Plasma 
therapy was earlier considered promising.  This therapy 
has been used for some Covid-19 patients in Delhi, 
Rajasthan, Punjab and Maharashtra and has shown 
promising results. ICMR has now specified that this 
therapy may not be effective against Covid-19 disease. 
This therapy only works when convalescent plasma 
has a high concentration of specific antibody against 
this disease or else is not beneficial (Chen et al., 2020). 
CRISPR SARS-CoV-2 test is a CRISR-Cas9 based 
technology recently approved by ICMR. This requires 
biosafety (BSL-2 level) precautions and uses a Thermal 
Cycler. It is said that no RTPCR confirmation is re-
quired in this test (ICMR, 2020a).  
Clinical features of Covid-19 infection  
Through studying the infection pattern of a novel coro-
navirus, the Centre for Disease Control and Prevention, 
USA recommended the incubation period of novel coro-
navirus of 14 days. However, for mildly symptomatic 
and asymptomatic cases, the infection may be earlier 
than this incubation period (Lauer et al., 2020; Li et al., 
2020). The common symptoms include fever, dry 
cough, fatigue, sore throat, nasal congestion, muscle 
soreness, respiratory distress; and others like dyspnea, 
myalgia or arthralgia, sputum production, diarrhoea, 
nausea or vomiting, lymphopenia, haemoptysis and 
loss of taste and smell. Severe cases may have pneu-
monia and/or multi-organ failure in severe patients. The 
multi-organ dysfunction is characterized by acute lung 
failure, acute liver failure, acute kidney injury, cardio-
vascular disease as well as a wide spectrum of haema-
tological abnormalities and neurological disorders. A 
study on 21 patients from a tertiary care centre in India 
exhibited 57.1% of the patients to have the common 
clinical symptoms-fever (42.9%), cough (42.9%), sore 
throat (23.8%), headache (13.6%), dyspnea (4.8%) and 
patients (68.3%). They had also reported about 33.3% 
to have an only loss of smell, while about 23.3% with 
an impaired taste only, and 11.7% of covid-19 infected 
patients had impaired taste and smell (Wang et al., 
2020a). Occasionally the reason for the death of Covid-
19 cases of >60 years age is their underlying chronic 
medical conditions (lung disease, asthma, liver dis-
ease, cancer, renal disease, immune-compromising 
conditions) (Wang et al., 2020b). The viral load in se-
vere cases of covid-19 is higher around 60 times than 
in mild cases. In mild cases, early viral clearance was 
also found when tested with RT-PCR (Reverse tran-
scriptase Polymerase Chain Reaction). Since negative 
RT-PCR results were found positive by chest CT scan, 
hence it is recommended for negative RT-PCR cases 
(Fang et al., 2020; Liu et al., 2020). Since no vaccine or 
drugs have been discovered, therefore, treatment is 
symptomatic and supportive through antiviral and anti-
inflammatory treatment (Jiang et al., 2020).  
Vaccination programme 
Even though strong measures are being taken in  
diagnosis and treatment of Covid-19, vaccine is the 
only long-term solution to break the chain of transmis-
sion. As of December 2020, 274 vaccine candidates in 
different stages of development. Since the number of 
vaccines available will be lesser than the population of 
India, the Government has strategised the population 
with priority of vaccination. Based on that, vaccine is 
being offered to healthcare workers first, then popula-
tion above 50 years of age, followed by the population 
below 50 years with co-morbidities and finally remain-
ing population.  Multiple vaccines are under develop-
Fig. 6. Pearson’s correlation analysis of the population 
density and affluence percentage with Covid-19 cases and 
deaths using Pearson's coefficient. 
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ment through one of the following techniques i.e., virus 
vaccines (using the whole virus in weakened or inacti-
vated form), viral vector vaccines (genetically engi-
neered coronavirus proteins are produced), nucleic 
acid vaccines (DNA or RNA), Protein-based vaccines 
(protein fragments or coronavirus is used). In Decem-
ber, 2020, 6 vaccines were under clinical trials. These 
are Covishield (Chimpanzee Adenovirus), Covaxin 
(Inactivated Virus), ZyCoV-D (DNA vaccine), Sputnik V 
(Human Adenovirus vaccine), NVX-CoV2373 (Protein 
Subunit) and Recombinant Protein Antigen based vac-
cine (Tregoning et al., 2020; ICMR (2020a, b). 
Two vaccines candidates from Bharat Biotech and Zy-
dus Cadila were under advance development (Dutta, 
2020). Out of these, Covaxin has been given emergen-
cy approval and this was developed by Bharat Biotech 
in collaboration with the Indian Council of Medical Re-
search (ICMR), New Delhi and National Institute of Vi-
rology (NIV), Pune.  It was under phase 3 human trial 
when ICMR in India approved it. The Covishield vac-
cine was prepared by Serum Institute of India, Pune, 
which has partnered with British pharmaceutical com-
pany Astra Zeneca. The covishield vaccine has been 
approved in UK and based on that given approval in 
India too. Vaccination started on January 16, 2021 with 
the highest number of people vaccinated on day 1. 
However, after vaccination, several adverse events 
(about 580) were reported, including two deaths (a 52-
year-old in Moradabad and a 42-year-old in Karnataka 
(Soutik, 2020; Manavi, 2021). 
Future challenges 
Transmission can also occur via touching infected sur-
faces like inanimate objects. Coronavirus can survive in 
the air as aerosol droplets for several hours, in water, 
sewage and also in faecal samples (SARS-CoV). 
Hence, for the control of transmission, it is essential to 
estimate transmissibility. The reinfection in recovered 
patients and asymptomatic cases which can spread the 
virus to their contacts has turned into a challenge. 
Thus, further investigations are desired to understand 
the possibility of reinfection with this new coronavirus 
(Lan et al., 2020). Younger population (< 15 
years) infected with Covid-19 are most prone to be 
asymptomatic (Bai et al., 2020). 
The effect of environmental factors like temperature, 
humidity and wind speed showed almost negligible to 
moderate influence as studied in China and Italy 
(Bhattacharjee, 2020). Less influence of warm and hu-
mid climate on transmission was also observed, but the 
popular belief of ending coronavirus with the onset of 
the summer season was thus rejected (Mecenas et al., 
2020). It can also persist in environmental media like 
sewage, water and faecal samples. There is an urgent 
need to study other environmental parameters like 
dust, particulate matter etc., for Covid-19 survival.  
The effective means of spreading pathogens like virus-
es between humans and wildlife is vectors like mosqui-
toes. The emergence of Zika virus transmitted by Ae-
des exemplifies the evolution and risks from viral patho-
gens (Singer, 2020). Several investigations showed the 
potential of nidoviruses to be transmitted by mosqui-
toes. For example, a study found CAVV (CAVV, coro-
navirus-like) isolated from Culex, Aedes, and Anophe-
les, with the most frequent being Culex (Junglen et al., 
2009). Two nidoviruses, Cavally virus (CavV) and Nam 
Dinh virus (NDiV) were isolated from mosquitoes. 
“DakNong virus (DKNV),” was isolated from Culex tri-
taeniorhynchus Giles (Diptera: Culicidae) in Vietnam 
with genome size similar to Cavally virus (CavV) and 
Nam Dinh virus (NDiV) (Kuwata et al., 2013). Presence 
of RNA transcripts/GE in M-DBSs of ZIKAV, and MERS
-CoV in An. gambiae shows its potential (Fauver et al., 
2017). These studies indicated the potential of mosqui-
toes to transmit viruses. Since strains of coronavirus 
showed high replication fidelity and adaptability hence 
may evolve to spread infection by vectors like mosqui-
toes. 
Several drugs and vaccines are under trial. Drugs like 
Umifenovir, MW Sepsivac are drugs working well under 
trial. Covaxin and Covishield have been given emer-
gency approval and is currently under usage for inocu-
lation and giving promising results. Other vaccines like 
ZyCoV-D, Biological E’s novel Covid-19 vaccine and 
Sputinik are the vaccines currently under trial (Naik et 
al., 2020). Vaccines require more attention towards the 
elderly as weaker immune response will be induced in 
them. The drugs and vaccines under trial, if approved, 
may help us to respond further against Covid-19 pan-
demic.  
Conclusion 
Covid-19 pandemic requires strict vigilance, tracking, 
quarantine. Social distancing, wearing of masks and 
washing of hands have also been advised and had 
proved fruitful. This study found that Arab countries 
were the highest contributors to India's early Covid-19 
cases through travellers. Metropolitan cities like Delhi, 
Mumbai, Pune, Chennai, Thrissur, Kozhikode, Thiru-
vananthapuram, etc. with more transport within and 
outside India were most responsible for transmission in 
India. Affluence and population density together act as 
factors impacting covid-19 cases. This is because the 
population from affluent areas travelled outside India 
and brought the virus with them. Once they came in 
contact with the virus individuals of affluent districts 
spread the virus to others which were transmitted more 
with densely populated areas. Indian males, age group 
21 to 40 (in case of morbidity) and > 60 (in case of mor-
tality) were found to be more susceptible to Covid-19 
disease. Two vaccines, i.e., Covishield and Covaxin 
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have been given emergency approval and are currently 
being inoculated to frontline workers. Thus, vaccines 
are a promising way of reducing Covid-19 transmission 
and soon, their results can be seen as a reduction in 
the number of cases. Further research on the role of 
environmental factors, reinfection in recovered patients, 
and mosquitoes' potential is necessary to be prepared 
against future emergence/resurgence of diseases 
caused by coronaviruses.  
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